REPORT: The Economic Case for Universal Pharmacare: Costs and benefits of publicly funded drug coverage for all Canadians
Posted: September 13, 2010
(September 13, 2010)
The Canadian Health Coalition has released an important and timely report in partnership with the Canadian Centre for Policy Alternatives. Authored by pharmaceutical policy expert Marc Andre Gagnon, the report shows that Canadians are paying far too much for drugs, and that our patchwork of public plans, private insurance and out-of-pocket costs is inequitable, overly expensive and inefficient. The Ontario government is leading the provinces in trying to establish a common purchasing plan for drugs so that they can levy bulk-buying power.